Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Serum cholesterol affects blood pressure regulation

Journal of Human Hypertension volume 16, pages 337–343 (2002)Cite this article

Abstract

A close relationship between abnormalities of the lipid metabolism and arterial hypertension has been observed in several epidemiological studies. The aim of the present study was to investigate whether serum cholesterol might affect blood pressure (BP) levels at rest, during ambulatory monitoring or during sympathetic stimulation—independently of other variables such as body weight or serum insulin—thus influencing the outcome of hypertensive complications. Seventy-three patients with sustained newly-discovered and never-treated hypertension were divided into tertiles according to their serum cholesterol levels and their resting BP, 24-h BP and BP during isometric exercise (handgrip) were compared. Cardiac mass and carotid wall thickness were measured by echographic technique. The results were that tertiles were similar for body weight, blood glucose and serum insulin, but different for serum cholesterol and triglycerides. BP at rest and during 24-h monitoring was similar in the three groups, whilst a significant difference was detected during sympathetic stimulation by handgrip, with systolic and diastolic BP increasing by 16/12, 28/19 and 30/23 mm Hg (P < 0.01) in lower, medium and higher tertiles, respectively. Intima-media layer of the carotid arteries was also significantly thickened in the groups with higher cholesterol levels (0.54 ± 0.07, 0.67 ± 0.14, 0.68 ± 0.15, P < 0.05). These data support the conclusion that even in patients with recently discovered hypertension, cholesterol levels may influence the BP response to adrenergic stimulation as well as the outcome of target organ disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Laurenzi M et al on behalf of the Gubbio Study Group. Multiple risk factors in hypertension: results from the Gubbio Study J Hypertens 1990; 8 (Suppl 1): S7–S12

    Article  Google Scholar 

  2. National Heart Foundation of Australia: risk factor prevalence study, report 1 National Heart Foundation of Australia: Canberra 1982

  3. Vallance P, Collier J, Moncada S . Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man Lancet 1989; 2: 997–1000

    Article  CAS  PubMed  Google Scholar 

  4. Resink TJ et al. Interaction between plasma lipoproteins and vascular smooth muscle cells: how relevant is it to arterial hypertension? Nutr Metab Cardiovasc Dis 1994; 4: 163–170

    CAS  Google Scholar 

  5. Creager MA et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans J Clin Invest 1990; 86: 228–234

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Clarkson P et al. Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults J Clin Invest 1996; 97: 1989–1994

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Johnson CJ, Kerr JH . Automatic blood pressure monitors. A clinical evaluation of five models in adults Anesthesia 1985; 40: 471–478

    Article  CAS  Google Scholar 

  8. Floras JS, Osman Hassan M, Jones JV, Sleight P . Pressor responses to laboratory stresses and daytime blood pressure variability J Hypertens 1987; 5: 715–719

    Article  CAS  PubMed  Google Scholar 

  9. Friedewald WT, Lery RI, Fredrickson DS . Estimation of plasma low density lipoprotein cholesterol concentration without use of the preparative ultracentrifuge Clin Chem 1972; 18: 499–502

    CAS  PubMed  Google Scholar 

  10. Sahn DJ, De Maria A, Kisslo J, Weyman A . The Committee on M-Mode Standardization of the American Society of Echocardiography: recommendations regarding quantitation in M-Mode echocardiography. Results of a survey of echocardiographic measurements Circulation 1978; 58: 1072–1083

    Article  CAS  PubMed  Google Scholar 

  11. Devereux RB, Reichek N . Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method Circulation 1977; 55: 613–618

    Article  CAS  PubMed  Google Scholar 

  12. de Simone G et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight J Am Coll Cardiol 1992; 20: 1251–1260

    Article  CAS  PubMed  Google Scholar 

  13. Teichholz LE, Kreulen T, Herman MV, Gorlin R . Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence or absence of asinergy Am J Cardiol 1976; 37: 7–11

    Article  CAS  PubMed  Google Scholar 

  14. Wallerson DC, Ganau A, Roman MJ, Devereux RB . Measurements of cardiac output by M-mode and two dimensional echocardiography: application topatients with hypertension Eur Heart J 1990; 11 (Suppl 1): 67–78

    Article  Google Scholar 

  15. Bond MG, Wilmoth SK, Enevold GL, Strickland HL . Detection and monitoring of asymptomatic atherosclerosis in clinical trials Am J Med 1989; 86 (Suppl 4A): 33–36

    Article  Google Scholar 

  16. Pignoli P et al. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging Circulation 1986; 74: 1399–1406

    Article  CAS  PubMed  Google Scholar 

  17. Ferrara LA et al. Early changes of the arterial carotid wall in uncomplicated primary hypertensivepatients. Study by ultrasound high-resolution B-mode imaging Arterioscler Thromb 1994; 14: 1290–1296

    Article  CAS  PubMed  Google Scholar 

  18. Levy D et al. Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study Ann Int Med 1988; 108: 7–13

    Article  CAS  PubMed  Google Scholar 

  19. Assmann G, Schulte H . The prospective cardiovascular Münster (Procam) study: prevalence of hyperlipidaemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease Am Heart J 1988; 116: 1713–1724

    Article  CAS  PubMed  Google Scholar 

  20. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societes on coronary prevention Eur Heart J 1998; 19: 1434–1503

  21. The International Task Force for prevention of coronary heart disease in cooperation with the International Atherosclerosis Society. Coronary heart disease: reducing the risk. The scientific background for primary and secondary prevention of coronary heart disease. A worldwide view Nutr Metab Cardiovasc Dis 1998; 8: 205–271

  22. Williams RR et al. Familial dyslipidemic hypertension. Evidence from 58 Utah families for a syndrome present in approximately 12% ofpatients with essential hypertension JAMA 1988; 259: 3579–3586

    Article  CAS  PubMed  Google Scholar 

  23. Ferrannini E et al. Insulin resistance in essential hypertension N Engl J Med 1987; 317: 350–357

    Article  CAS  PubMed  Google Scholar 

  24. Hunt SC, Williams RR, Smith JB, Ash KO . Associations of three erythrocytes cation transport system with plasma lipids in Utah subjects Hypertension 1986; 8: 30–36

    Article  CAS  PubMed  Google Scholar 

  25. Reaven GR . Role of insulin resistance in human disease Diabetes 1988; 37: 1595–1607

    Article  CAS  PubMed  Google Scholar 

  26. Musgrave IF, Bachmann AW, Saar N, Gordon RD . A comparison of cardiovascular and catecholamine responses to three stimuli in mild hypertension Metabolism 1984; 33: 718–723

    Article  CAS  PubMed  Google Scholar 

  27. Guida L et al. Clinic-daytime blood pressure difference and cardiovascular damage J Hypertens 1999; 17: 331–337

    Article  CAS  PubMed  Google Scholar 

  28. Ferrara LA et al. Olive oil and reduced need for antihypertensive medications Arch Intern Med 2000; 160: 837–842

    Article  CAS  PubMed  Google Scholar 

  29. Hamada M et al. Enhanced blood pressure response to isometric handgrip exercise with essential hypertension: effects of propanolol and razosin J Hypertens 1987; 5: 305–309

    Article  CAS  PubMed  Google Scholar 

  30. Salonen JT, Salonen R . Ultrasonographically assessed carotid morphology and the risk of coronary artery disease Arterioscler Thromb 1991; 11: 1245–1249

    Article  CAS  PubMed  Google Scholar 

  31. Hayakawa H, Raij L . Relationship between hypercholesterolemia, endothelial dysfunction and hypertension J Hypertens 1999; 17: 611–619

    Article  CAS  PubMed  Google Scholar 

  32. Creager MA, Selwyn A . When ‘normal’ cholesterollevels injure the endothelium Circulation 1997; 96: 3255–3257

    CAS  PubMed  Google Scholar 

  33. Nazzaro P et al. Distinct and combined vascular effects of ACE blockade and HMG – CoA reductase inhibition in hypertensive subjects Hypertension 1999; 33: 719–725

    Article  CAS  PubMed  Google Scholar 

  34. Sung BH, Izzo JL, Wilson MF . Effects of cholesterol reduction on BP response to mental stress inpatients with high cholesterol Am J Hypertens 1997; 10: 592–599

    Article  CAS  PubMed  Google Scholar 

  35. Poli A et al. Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemicpatients Atherosclerosis 1988; 70: 253–261

    Article  CAS  PubMed  Google Scholar 

  36. Heiss G et al the ARIC Investigators. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC Study Am J Epidemiol 1991; 134: 250–256

    Article  CAS  PubMed  Google Scholar 

  37. Pan WH, Bai CH, Chen JR, Chiu HC . Associations between carotid atherosclerosis and high factor VIII activity, dyslipidemia, and hypertension Stroke 1997; 28: 88–94

    Article  CAS  PubMed  Google Scholar 

  38. Roman MJ et al. Relation of blood pressure variability to carotid atherosclerosis and carotid artery and left ventricular hypertrophy Arterioscler Thromb Vasc Biol 2001; 21: 1507–1511

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors are grateful to Mrs Rosanna Scala for her linguistic revision.

Author information

Authors and Affiliations

  1. Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy

    L A Ferrara, L Guida, R Iannuzzi, A Celentano & F Lionello

Authors
  1. L A Ferrara
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L Guida
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R Iannuzzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A Celentano
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F Lionello
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L A Ferrara.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ferrara, L., Guida, L., Iannuzzi, R. et al. Serum cholesterol affects blood pressure regulation. J Hum Hypertens 16, 337–343 (2002). https://doi.org/10.1038/sj.jhh.1001388

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001388

Keywords

This article is cited by

Search

Advanced search

Quick links